Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Agenus Inc
(NQ:
AGEN
)
3.160
USD
-0.235 (-6.92%)
Official Closing Price
Updated: 7:50 PM EST, Mar 4, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Agenus Inc
< Previous
1
2
...
24
25
26
27
28
29
30
31
Next >
Recently Released Market Study: GSK's MAGE-A3 Cancer Immunotherapeutic Phase 3 Study in Melanoma Misses First Co-Primary Endpoint
September 05, 2013
New York, NY -- (SBWIRE) -- 09/05/2013 -- Agenus Inc., (NASDAQ:AGEN) a developer of treatments for cancer and infectious diseases, plummeted the most in four years after partner GlaxoSmithKline Plc’s...
From
SBWire - Latest Press Releases
Hot Stock: Antigenics, Shares Drop 33.2% (AGEN)
September 05, 2013
From
Comtex SmarTrend® News Briefs
Catalyst Pharmaceutical Partners Inc. (NASDAQ:CPRX) and Agenus Inc. (NASDAQ:AGEN) Added to Equity Profile Report's NASDAQ Decliners Watch List.
September 05, 2013
Wilmington, DE -- (SBWIRE) -- 09/05/2013 -- Equity Profile Report expands its NASDAQ Decliners Weekly Watch List adding Catalyst Pharmaceutical Partners Inc. (NASDAQ:CPRX) and Agenus Inc....
From
SBWire - Latest Press Releases
Higher Open As Jobless Claims Fall
September 05, 2013
First time applications for unemployment benefits fell to a five year low to lift the markets to a higher open with the Dow gaining 30 points to 14,960. Nasdaq rose 10 points to 3659.
Tags
Market News
From
MarketMinute.com Market Updates
Antigenics: The Losing Streak Continues (AGEN)
September 05, 2013
From
Comtex SmarTrend® News Briefs
Morning Market Losers
September 05, 2013
Agenus (NASDAQ: AGEN ) dropped 32.35% to $2.51. Agenus shares have dropped 25.20% over the past 52 weeks, while the S&P 500 index has gained 15.43% in the same period. Bazaarvoice (NASDAQ: BV )...
Tags
US6065011040
News
CONN
From
Benzinga
Higher Open As Jobless Claims Fall
September 04, 2013
Tags
Market Updates
CONN
KDN
From
MarketMinute » Market Updates
GSK’s MAGE-A3 Cancer Immunotherapeutic Phase 3 Study in Melanoma Misses First Co-Primary Endpoint
September 04, 2013
From
Business Wire News Releases
Agenus to Present at Two Upcoming Healthcare Conferences
September 04, 2013
From
Business Wire News Releases
Traders Get Bullish on Shares of Antigenics, Shares Up 7.9% (AGEN)
August 22, 2013
From
Comtex SmarTrend® News Briefs
Agenus Reports Second Quarter 2013 Financial Results
July 25, 2013
Agenus to Host Conference Call Beginning at 11 a.m. ET Today
From
GlobeNewswire News Releases
Mentor Capital Cancer Immunotherapy Index Gains 31% During First Half of 2013
July 19, 2013
From
Business Wire News Releases
Hot Stock: Antigenics, Shares Gain 5.2% (AGEN)
July 18, 2013
From
Comtex SmarTrend® News Briefs
Agenus to Report Second Quarter 2013 Financial Results on July 25, 2013; Conference Call to Follow
July 18, 2013
From
GlobeNewswire News Releases
Agenus to Present at the JMP Securities Annual Healthcare Conference
July 02, 2013
From
GlobeNewswire News Releases
Agenus to Webcast Annual Shareholders' Meeting
June 10, 2013
From
GlobeNewswire News Releases
Agenus Announces Initiation of Enrollment in NCI-Sponsored Randomized Trial of Prophage G-200 Vaccine With Avastin in Treatment of Brain Tumors
May 22, 2013
Study Seeking to Enroll 222 Patients; Largest Vaccine Trial Ever Funded by NCI in Brain Tumors and the Largest Cancer Vaccine Study Ever Conducted in Combination With Avastin
From
GlobeNewswire News Releases
1 Stock to Buy, 1 Stock to Short: Small-Cap Pharma
May 16, 2013
Tags
NASDAQ:PPHM
NASDAQ:AGEN
From
InvestorPlace
Mentor Capital Cancer Immunotherapy Index Gains 28% During First Quarter of 2013
May 02, 2013
From
Business Wire News Releases
Positive Phase 2 Data from Agenus' Brain Cancer Vaccine Presented at Plenary Session of American Academy of Neurological Surgeons Meeting
May 01, 2013
Newly Diagnosed Patients With Brain Tumors Treated With Prophage Vaccine Show Improvement in Progression Free Survival and Overall Survival Compared to Standard of Care
From
GlobeNewswire News Releases
Agenus Reports First Quarter 2013 Financial Results
April 24, 2013
Agenus to Host Conference Call Beginning at 11 a.m. ET Today
From
GlobeNewswire News Releases
Agenus to Report First Quarter 2013 Financial Results on April 24, 2013; Conference Call to Follow
April 18, 2013
From
GlobeNewswire News Releases
Agenus Eliminates Its $39 Million Senior Notes and Completes $10 Million of New Debt Financing
April 16, 2013
From
GlobeNewswire News Releases
Agenus' Brain Cancer Vaccine Results to be Presented at Plenary Session of the 81st American Association of Neurological Surgeons (AANS) Annual Scientific Meeting
April 10, 2013
First Phase 2 Data From Prophage G-100 (HSPPC-96) Newly Diagnosed Glioma Program
From
GlobeNewswire News Releases
Notable Microcap Stocks: Manning and Napier Inc, Reed's, Affymax, Agenus Inc
March 19, 2013
Lakeway, TX -- (SBWIRE) -- 03/19/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the...
From
SBWire - Latest Press Releases
Mentor Capital Cancer Immunotherapy Index Gains 32% YTD and Adds Second Generation Firms for 2013
March 15, 2013
From
Business Wire News Releases
Agenus to Present at the ROTH Annual Conference
March 14, 2013
From
GlobeNewswire News Releases
UPDATE: Dawson James Reiterates Agenus Inc. at Buy After Rapid Phase II Trial Enrollment on HerbV
March 12, 2013
In a report published by Dawson James, analyst Robert M. Wasserman reiterated a Buy rating and $6.00 price target on Agenus, Inc. (NASDAQ: AGEN ) Dawson James reported that, “Key developments for the...
Tags
Analyst Color
Dawson James
AGEN
From
Benzinga
NW Bio Provides Guidance On Phase III Trial Enrollment Timing: Completion Expected To Be Faster Or More Efficient Than Relevant Comparison Trials
March 07, 2013
From
PR Newswire
Agenus Reports Fourth Quarter and Year End 2012 Financial Results
February 27, 2013
Agenus to Host Conference Call Beginning at 11 a.m. ET Today
From
GlobeNewswire News Releases
< Previous
1
2
...
24
25
26
27
28
29
30
31
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.